# Quinoa Blood Glucose Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/quinoa-blood-glucose-randomized-trial-evidence-review
Category: evidence-review
Summary: Quinoa Blood Glucose Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are r
Last reviewed: 2026-07-24
Reviewed by: Migaku Evidence Review
# Quinoa Blood Glucose Randomized Trial: What the Evidence Says

## Quick Answer

Quinoa Blood Glucose Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Quinoa Improves Glucose Metabolism and Fluctuation Based on β-Cell Function in Early-Stage Type 2 Diabetes Mellitus: A Randomized Study | randomized trial | 2 | 2026-02-04 | 10.2147/IJGM.S584727 |
| Physiological Advantages of a Fiber-Enriched Plant-Based Dessert: Improved Glycemic Control and Appetite Regulation over a Commercial Dairy Product | research article | 4 | 2026-02-10 | 10.1021/acsomega.5c10700 |

## What The Sources Report

- The calculations were performed according to the Chinese Type 2 Diabetes Prevention and Treatment Guidelines (2024 edition) and the American Diabetes Association's Standards of Care in Diabetes-2024, which recommend that starchy foods (carbohydrates) should contribute 45%-60% of the total daily energy intake for adults with diabetes, with fat comprising 20%-30% and protein 15%-20%. [Zhang Jianbo (2026); evidence level 2]
- Multivariate logistic regression analysis was conducted to identify factors associated with the reduction or cessation of hypoglycaemic medications. [Zhang Jianbo (2026); evidence level 2]
- Noncommunicable diseases
(NCDs) remain the foremost cause of global
mortality, largely driven by modifiable risk factors such as unhealthy
diets and sedentary behavior.The escalating
prevalence of obesity and metabolic disorders underscores the need
for nutritional strategies that combine physiological efficacy with
technological innovation. [Pereira Maria Tereza Lucena (2026); evidence level 4]
- Recent advances
in food technology have made it possible to reformulate
traditional high-sugar, high-fat desserts, typically associated with
unfavorable metabolic effects, into health-promoting alternatives
without compromising sensory appeal. [Pereira Maria Tereza Lucena (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For quinoa blood glucose randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Zhang Jianbo (2026). Quinoa Improves Glucose Metabolism and Fluctuation Based on β-Cell Function in Early-Stage Type 2 Diabetes Mellitus: A Randomized Study. DOI: 10.2147/IJGM.S584727. PMCID: PMC13012631. PMID: 41883469. License: https://creativecommons.org/licenses/by-nc/4.0/ https://www.dovepress.com/terms.php http://creativecommons.org/licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13012631/
- Pereira Maria Tereza Lucena (2026). Physiological Advantages
of a Fiber-Enriched Plant-Based
Dessert: Improved Glycemic Control and Appetite Regulation over a
Commercial Dairy Product. DOI: 10.1021/acsomega.5c10700. PMCID: PMC12947189. PMID: 41768746. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12947189/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.